Shilpak Chatterjee
7PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 20, 2026
S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors.Debashree Basak, Puspendu Ghosh, Anupam Gautam
|Mar 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor.Ishita Sarkar, Debashree Basak, Puspendu Ghosh
|Aug 11, 2023
Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer.Debashree Basak, Soumya Mondal, Swadeep Kumar Srivastava
|Feb 28, 2023
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19.Ranit D'Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay
|Jun 01, 2022
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells.Snehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik
|Apr 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function.Paramita Chakraborty, Rasesh Y Parikh, Seungho Choi
Pageof 2
Frequent Collaborators
4 joint publications
Snehanshu Chowdhury
3 joint publications
Sandip Paul
3 joint publications
Puspendu Ghosh
3 joint publications
Shikhar Mehrotra
3 joint publications
Anupam Gautam
2 joint publications
Soumya Mondal
2 joint publications
Shaun Mahanti
2 joint publications
Anwesha Kar
1 joint publications
Monika Gooz
1 joint publications
Hongjun Wang
